Cantitate/Preț
Produs
Total produse
Vezi coșul
Neuroendocrine Tumours: Diagnosis and Management de Suayib Yalcin

Neuroendocrine Tumours: Diagnosis and Management

Editat de Suayib Yalcin, Kjell Öberg
en Limba Engleză Hardback – 10 iun 2015
This book is a timely textbook that covers all aspects of neuroendocrine tumors (NET) from epidemiology, pathological classification and evaluation and molecular biology through to diagnostic imaging methods and therapeutic options, including the latest targeted therapies. The various types of NET are individually discussed, including carcinoid tumors, insulinomas, gastrinomas, glucagonomas, VIPomas, somatostatinomas, PPomas, medullary thyroid carcinomas, adrenocortical cancer, pheochromocytomas, paragangliomas and non-functioning pancreatic NETs. The contributing authors are internationally recognized experts who bring a wealth of experience to the subject. This book will be an invaluable source of information for practicing medical oncologists, surgeons, endocrinologists, gastroenterologists and pathologists and also trainees.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Hardback (2) 69171 lei  38-45 zile
  Springer International Publishing – 13 sep 2024 150789 lei  3-5 săpt.
  Springer Berlin, Heidelberg – 10 iun 2015 69171 lei  38-45 zile

Preț: 69171 lei

Preț vechi: 72811 lei
-5% Nou

Puncte Express: 1038
Preț estimativ în valută:
13236€ • 13819$ • 10954£

Carte tipărită la comandă

Livrare economică 31 martie-07 aprilie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783662452141
ISBN-10: 3662452146
Pagini: 300
Ilustrații: VII, 578 p. 83 illus., 44 illus. in color.
Dimensiuni: 155 x 235 x 30 mm
Greutate: 0.99 kg
Ediția:2015
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Professional/practitioner

Cuprins

Introduction.- Historical Background.- Epidemiology.- Pathological Classification.- Carcinoid Syndrome.- Molecular Biology.- İnsulinoma.- Gastrinoma.- Vipoma.- Glucagonoma.- Pathological Evaluation.- Radiological Imaging.- Nuclear Imaging.- Genetic  Syndromes Associated with NET.- Surgical Approach.- Locoregional treatment (RFA).- Embolization (Chemo/radio).- PRRT.- Management of Hormonal symptoms.- Chemotherapy.- Somatostatin Analogues.- Targeted Therapies.- Guidelines.- Societies and Guidelines.- Biomarkers.- Medullary Thyroid Cancer.- Adrenocortical Cancer.- Paraganglioma, feokromositoma.- Nonfonksiyone pNET.- Somatostatinoma.- Poorly differentiated NET.- Management of MEN.- Ppoma.​

Textul de pe ultima copertă

This book is a timely textbook that covers all aspects of neuroendocrine tumors (NET) from epidemiology, pathological classification and evaluation, and molecular biology through to diagnostic imaging methods and therapeutic options, including the latest targeted therapies. The various types of NET are individually discussed, including carcinoid tumors, insulinomas, gastrinomas, glucagonomas, VIPomas, somatostatinomas, PPomas, medullary thyroid carcinomas, adrenocortical cancer, pheochromocytomas, paragangliomas, and non-functioning pancreatic NETs.
 The contributing authors are internationally recognized experts who bring a wealth of experience to the subject. This book will be an invaluable source of information for practicing medical oncologists, surgeons, endocrinologists, gastroenterologists, and pathologists and also trainees.
 

Caracteristici

Covers all aspects of the subject, from pathological evaluation and molecular biology through to diagnostic imaging and the latest therapeutic options Discusses the full range of neuroendocrine tumors Written by internationally recognized experts who bring a wealth of experience to the subject

Notă biografică

​Kjell Öberg is Professor of Endocrine Oncology at the Medical Faculty of Uppsala University and a former head of the Department of Endocrine Oncology, University Hospital, Uppsala. He is also Adjunct Professor of Surgery at Vanderbilt University, Nashville, Tenn., USA.  Dr. Öberg is a specialist in endocrinology and internal medicine with 40 years’ experience in the field of neuroendocrine tumors. He was one of the founders and coordinator of the European Neuroendocrine Tumor Network (ENET) (1995–2000), the president of ENETs 2010-2012 and is a past chairman of the Nordic Neuroendocrine Tumor Group. He has pioneered the treatment of carcinoid tumor patients with interferon and somatostatin analogs and developed assays for tumor markers such as chromogranin A and radiological procedures including specialized PET scans. Dr. Öberg has received numerous awards, including most recently the Rudbeck Medallion for excellence in research (2014), a Lifetime Achievement Awardfrom the North American Neuroendocrine Society (2014), The Swedish Endocrine Society Gold Medal for prominent research and clinical activities (2017), and a Lifetime Achievement Award from the European Neuroendocrine Tumor Society (ENETS), of which he has been Vice President since 2012.
Suayib Yalcin is a medical oncologist with a special interest in gastrointestinal cancer treatment and research who is a full professor at Hacettepe University Cancer Institute, Turkey. Dr. Yalcin has served as Director of the Hacettepe University Oncology Hospital and Head of the Hacettepe University Medical Oncology Department. He has held a variety of important posts in medical organizations, including President of Turkish Society of Medical Oncology, General Secretary of Turkish Oncology Group, and National Representative of ESMO in Turkey. Currently he is President of the Turkish Association of Cancer Research and Control and President of Hacettepe Oncology Association.He is an active member of ASCO, ESMO, EORTC, and MMOF. Dr. Yalcin has participated in many clinical cancer research projects as a steering committee member or principal investigator and serves on the editorial board of several cancer journals. He has been the conference chair of the International Gastrointestinal Cancer Conference (www.igicc2017.org) for the past 7 years.  He has authored or co-authored more than 100 articles cited in Science Citation Index.